Real-world efficacy and safety of dividing aflibercept into three syringes in the treatment of wet age-related macular degeneration

Acta Ophthalmol. 2019 Aug;97(5):e812-e813. doi: 10.1111/aos.14051. Epub 2019 Feb 14.
No abstract available

Publication types

  • Letter

MeSH terms

  • Dose-Response Relationship, Drug
  • Drug Costs*
  • Humans
  • Intravitreal Injections
  • Receptors, Vascular Endothelial Growth Factor / administration & dosage*
  • Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors
  • Recombinant Fusion Proteins / administration & dosage*
  • Recombinant Fusion Proteins / economics
  • Syringes*
  • Wet Macular Degeneration / drug therapy*

Substances

  • Recombinant Fusion Proteins
  • aflibercept
  • Receptors, Vascular Endothelial Growth Factor